Pfizer (PFE) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Feb 04, 2025, 10:30 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants.
FiercePharma14h
Pfizer harnesses COVID fluctuations to clinch Q4 gains as RSV vaccine sales plummet
After a period of unsteady sales for its key COVID-19 products, Pfizer now sees COVID-related revenue volatility as “largely ...
precisionmedicineonline10h
Pfizer Reports 27 Percent Oncology Growth in Q4, Touts Progress in ADC and Breast Cancer Trials
The firm recorded Q4 oncology revenues of $4.06 billion compared to $3.19 billion in the same period last year.
Pfizer Shares Fall Despite EPS Soaring 530% in Q4
Pfizer ( PFE, Financial) stock dropped more than 2% at the start of the stock market opening Tuesday after the company posted ...
Pfizer Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Analysts expect the New York-based company to report quarterly earnings at 46 cents per share, up from 10 cents per share in ...